The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 14, 2020

Filed:

Jun. 13, 2019
Applicant:

Ojai Retinal Technology, Llc, Ojai, CA (US);

Inventors:

Jeffrey K. Luttrull, Ojai, CA (US);

David B. Chang, Tustin, CA (US);

Benjamin W. L. Margolis, Oakland, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 9/008 (2006.01); A61N 5/06 (2006.01); A61B 90/00 (2016.01); A61N 7/00 (2006.01); A61N 5/04 (2006.01); A61F 9/007 (2006.01); A61N 5/02 (2006.01); A61B 18/20 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61N 5/067 (2006.01);
U.S. Cl.
CPC ...
A61F 9/008 (2013.01); A61B 18/20 (2013.01); A61B 90/36 (2016.02); A61F 9/007 (2013.01); A61F 9/00821 (2013.01); A61N 5/025 (2013.01); A61N 5/045 (2013.01); A61N 5/06 (2013.01); A61N 5/0603 (2013.01); A61N 5/0625 (2013.01); A61N 7/00 (2013.01); A61B 17/00 (2013.01); A61B 2017/00061 (2013.01); A61B 2018/00589 (2013.01); A61B 2090/3735 (2016.02); A61F 9/00817 (2013.01); A61F 2009/00863 (2013.01); A61F 2009/00872 (2013.01); A61N 5/0622 (2013.01); A61N 2005/063 (2013.01); A61N 2005/0604 (2013.01); A61N 2005/067 (2013.01); A61N 2005/0607 (2013.01); A61N 2005/0608 (2013.01); A61N 2005/0609 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0662 (2013.01); A61N 2007/0004 (2013.01); A61N 2007/0043 (2013.01);
Abstract

A process for preventing or treating myopia includes applying a pulsed energy, such as a pulsed light beam, to tissue of an eye having myopia or a risk of having myopia. The source of pulsed energy has energy parameters including wavelength or frequency, duty cycle and pulse train duration, which are selected so as to raise an eye tissue temperature to achieve therapeutic or prophylactic effect, such as stimulating heat shock protein activation in the eye tissue. The average temperature rise of the eye tissue over several minutes is maintained at or below a predetermined level so as not to permanently damage the eye tissue.


Find Patent Forward Citations

Loading…